Table 1. Cbl-c mutations by tumor type in TCGA.
Cancer Type | N | Missense | Truncations | In-frame Indels | Other* |
---|---|---|---|---|---|
All Sites | 27,437 | 97 | 13 | 0 | 2 |
Hematological | 1,393 | 7 | 0 | 0 | 0 |
Lymphoid | 1164 | 7 | 0 | 0 | 0 |
Myeloid | 229 | 0 | 0 | 0 | 0 |
Solid Tumors | 26,044 | 90 | 13 | 0 | 2 |
Aerodigestive | |||||
Head and Neck | 827 | 1 | 0 | 0 | 0 |
Nasopharyngeal | 56 | 0 | 0 | 0 | 0 |
Salivary Gland | 214 | 0 | 0 | 0 | 0 |
Lung (Non-Small Cell) | 2591 | 6 | 2 | 0 | 0 |
Lung (Small Cell) | 190 | 1 | 0 | 0 | 0 |
Mesothelioma | 109 | 0 | 0 | 0 | 0 |
Esophagus | 557 | 4 | 0 | 0 | 0 |
Stomach | 1267 | 7 | 1 | 0 | 0 |
Liver | 983 | 4 | 0 | 0 | 0 |
Ampullary Carcinoma | 160 | 2 | 0 | 0 | 0 |
Cholangiocarcinoma | 91 | 0 | 0 | 0 | 0 |
Gall Bladder | 32 | 0 | 0 | 0 | 0 |
Pancreas | 832 | 0 | 0 | 0 | 0 |
Colon | 1,462 | 11 | 3 | 0 | 0 |
Brain | 3,200 | 9 | 0 | 0 | 0 |
Breast Cancer | 4,110 | 5 | 2 | 0 | 0 |
Endocrine/Neuroendocrine | |||||
Adrenal Cortical | 92 | 0 | 0 | 0 | 0 |
Thyroid | 516 | 0 | 0 | 0 | 0 |
Pancreatic Neuroendocrine | 118 | 0 | 0 | 0 | 0 |
Pheochromocytoma | 184 | 0 | 0 | 0 | 0 |
Genitourinary | |||||
Bladder | 705 | 1 | 0 | 0 | 0 |
Kidney | 1,387 | 2 | 0 | 0 | 0 |
Prostate | 2,470 | 3 | 0 | 0 | 0 |
Testicular | 156 | 1 | 0 | 0 | 0 |
Gynecological | |||||
Ovary | 615 | 2 | 1 | 0 | 0 |
Endometrial | 627 | 4 | 2 | 0 | 0 |
Cervical | 309 | 2 | 1 | 0 | 0 |
Sarcoma | 732 | 1 | 0 | 0 | 0 |
Skin | |||||
Melanoma | 900 | 23 | 1 | 0 | 2 |
Squamous | 29 | 1 | 0 | 0 | 0 |
*Mutations in splice regions that could cause missplicing